K-Bio Lab Hub Project Promotion Team Signs Business Agreement to Support Vaccine and New Drug Development
The K-Bio Lab Hub Project Promotion Team of the Small and Medium Business Technology Information Promotion Agency signed a Memorandum of Understanding (MOU) on the 23rd with the Vaccine Global Industrialization Infrastructure Project Group to discover and nurture innovative startup companies.
K-Bio Lab Hub Director Han In-seok (left in photo) and Vaccine Global Industrialization Infrastructure Project Group Chairman Seol Dae-woo (right in photo) are taking a commemorative photo after signing the business agreement.
[Photo by Korea Technology and Information Promotion Agency for SMEs (TIPA)]
The contents of the MOU include △ cooperation in policy and new project discovery to support vaccine and new drug development △ exchange and cooperation among vaccine and new drug developers and researchers for future infectious disease response △ cooperation in the development and operation of facilities, human resources, and educational programs.
Han In-seok, head of the promotion team, stated, "To discover and nurture innovative bio companies, solid cooperation plans among related organizations are essential, and through such exchange and communication, the development of the pharmaceutical and bio industries will be accelerated."
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- The Era of 1.1 Million Foreign Workers: Ministry of Culture, Sports and Tourism and Hyundai Motor Group Introduce 'Safety Korean' to Manufacturing Sites
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Seol Dae-woo, director of the Vaccine Project Group, said, "The foundation supports bio companies based on global-level GMP (Good Manufacturing Practice) facilities, and through cooperation between the two organizations, we will strive to enable bio companies to rapidly develop vaccines and new drugs."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.